We are live on ! Find out more
KA

Kinnevik AB Portfolio holdings

AUM $65.6M
1-Year Est. Return 25.95%
This Fund
S&P 500
This Quarter Est. Return
+28.89%
1 Year Est. Return
-25.95%
3 Year Est. Return
-51.41%
5 Year Est. Return
10 Year Est. Return
AUM
$103M
AUM Growth
+$23M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.58B
$103M 100%
10,405,668

Similar funds

Kinnevik AB's Q4 2023 Portfolio in Review

As of Q4 2023, Kinnevik AB held 1 position worth $103M, up 29% from $79.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. Kinnevik AB opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Kinnevik AB's ten largest holdings make up 100% of its $103M portfolio in Q4 2023.
  • Kinnevik AB opened 0 new positions and closed 0 in Q4 2023.
  • Kinnevik AB's portfolio value rose 29% quarter-over-quarter to $103M.

Based on Kinnevik AB's 13F filing for Q4 2023, filed 2 Feb 2024.